Tingting Zhu, Jie Peng^*
The First Affiliated Hospital of Yangtze University, Jingzhou, China.
DOI: 10.4236/ojmi.2026.161009   PDF    HTML     95 Downloads   420 Views   Citations

Abstract

Short Retraction Notice The paper does not meet the standards of "Open Journal of Medical Imaging". This article has been retracted to straighten the academic record. In making this decision the Editorial Board follows COPE's Retraction Guidelines. The aim is to promote the circulation of scientific research by offering an ideal research publication platform with due consideration of internationally accepted standards on publication ethics. The Editorial Board would like to extend its sincere apologies for any inconvenience this retraction may have caused. Please see the article page for more details. The full retraction notice in PDF is preceding the original paper which is marked "RETRACTED".

Keywords

Hepatic Steatosis, MRI-PDFF, MASLD

Share and Cite:

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1]	Younossi, Z.M., Golabi, P., Paik, J.M., Henry, A., Van Dongen, C. and Henry, L. (2023) The Global Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review. Hepatology, 77, 1335-1347.[CrossRef] [PubMed]
[2]	Huang, Y., Sun, C., Wang, Y., Cheng, J., Wang, S., Wei, L., et al. (2025) Ultrasound-Guided Attenuation Parameter for Identifying Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Study. Ultrasonography, 44, 134-144.[CrossRef] [PubMed]
[3]	Imajo, K., Toyoda, H., Yasuda, S., Suzuki, Y., Sugimoto, K., Kuroda, H., et al. (2022) Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis with Reference to MRI-PDFF in a Large Cohort. Clinical Gastroenterology and Hepatology, 20, 2533-2541.e7.[CrossRef] [PubMed]
[4]	Cannella, R., Agnello, F., Porrello, G., Spinello, A.U., Infantino, G., Pennisi, G., et al. (2024) Performance of Ultrasound-Guided Attenuation Parameter and 2D Shear Wave Elastography in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. European Radiology, 35, 2339-2350.[CrossRef] [PubMed]
[5]	Nakamura, Y., Hirooka, M., Koizumi, Y., Yano, R., Imai, Y., Watanabe, T., et al. (2024) Diagnostic Accuracy of Ultrasound-Derived Fat Fraction for the Detection and Quantification of Hepatic Steatosis in Patients with Liver Biopsy. Journal of Medical Ultrasonics, 52, 85-94.[CrossRef] [PubMed]
[6]	Xue, L., Zhu, Y., Cheng, G., Han, H., He, N., Chen, L., et al. (2025) Ultrasound-Derived Fat Fraction for the Noninvasive Quantification of Hepatic Steatosis: A Prospective Multicenter Study. Insights into Imaging, 16, Article No. 237.[CrossRef]
[7]	Huang, Y., Li, J., Liu, C., Song, D., Zhu, C., Ren, Y., et al. (2025) Noninvasive Quantification of Hepatic Steatosis Using Ultrasound-Derived Fat Fraction (CHESS2303): A Prospective Multicenter Study. MedComm, 6, e70123.[CrossRef] [PubMed]
[8]	Cao, X.E., Zhang, Y.L., Jia, L.Z., et al. (2025) Comparative Diagnostic Value of Ultrasound-Derived Fat Fraction, Controlled Attenuation Parameter, and Hepatorenal Echo Ratio in Grading Hepatic Steatosis in Metabolic-Associated Fatty Liver Disease. Journal of Clinical Hepatology, 41, 1788-1794.
[9]	Wang, M.X., Shan, T., Yu, J., et al. (2025) Ultrasound-Based Quantitative Assessment of Fat Fraction in Chronic Liver Disease with Steatosis: A Controlled Study with Pathology. Chinese Journal of Ultrasound in Medicine, 41, 161-164.
[10]	Gottfriedova, H., Dezortova, M., Sedivy, P., Pajuelo, D., Burian, M., Sticova, E., et al. (2025) Comparison of Ultrasound to MR and Histological Methods for Liver Fat Quantification. European Journal of Radiology, 183, Article ID: 111931.[CrossRef] [PubMed]
[11]	Nasir, M., Xu, Y., Hasenstab, K., Yechoor, A., Dodhia, R., Weeks, W.B., et al. (2025) Liver MRI Proton Density Fat Fraction Inference from Contrast Enhanced CT Images Using Deep Learning: A Proof-of-Concept Study. PLOS One, 20, e0328867.[CrossRef] [PubMed]
[12]	Derstine, B.A., Holcombe, S.A., Chen, V.L., Pai, M.P., Sullivan, J.A., Wang, S.C., et al. (2025) Quantification of Hepatic Steatosis on Post-Contrast Computed Tomography Scans Using Artificial Intelligence Tools. Abdominal Radiology, 51, 991-1003.[CrossRef] [PubMed]
[13]	Hua, X.W., Fang, M., You, W.Y., et al. (2025) Accuracy Analysis of Magnetic Resonance FACT Sequence in Diagnosing Non-Alcoholic Fatty Liver Disease. Journal of Clinical Radiology, 44, 1030-1034.
[14]	Xu, L., MBlake, G., Guo, Z., et al. (2017) Correlation Study Between Quantitative CT and MR mDixon-Quant for Measuring Liver Fat Content. Radiology Practice, 32, 456-461.
[15]	Zhang, H.R., Bai, Z., Su, D.Y., et al. (2025) Artificial Intelligence Model-Based Measurement of Liver Fat Content Using Abdominal Plain CT: A Comparative Study with QCT. Radiology Practice, 40, 1011-1017.
[16]	Zhang, C.M., Ding, Z.M., Sun, X.Y., et al. (2024) Preliminary Study on the Combined Use of Quantitative CT Liver Fat Content and Clinical Indicators to Predict the Risk of Esophageal and Gastric Variceal Bleeding in Patients with Liver Cirrhosis. Radiology Practice, 39, 902-906.
[17]	Schwartz, F.R., Ashton, J., Wildman-Tobriner, B., Molvin, L., Ramirez-Giraldo, J.C., Samei, E., et al. (2023) Liver Fat Quantification in Photon Counting CT in Head to Head Comparison with Clinical MRI—First Experience. European Journal of Radiology, 161, Article ID: 110734.[CrossRef] [PubMed]
[18]	Lin, H., Xu, X., Deng, R., Xu, Z., Cai, X., Dong, H., et al. (2024) Photon-Counting Detector CT for Liver Fat Quantification: Validation across Protocols in Metabolic Dysfunction-Associated Steatotic Liver Disease. Radiology, 312, e240038.[CrossRef] [PubMed]
[19]	Panta, R.K., Yin, Z., Grönberg, F., Wildman-Tobriner, B., Bhattarai, M., Abadi, E., et al. (2025) Liver Fat Quantification Using Deep Silicon Photon-Counting CT: An in Silico Imaging Study. Radiology Advances, 2, umaf031.[CrossRef]
[20]	Loomba, R., Neuschwander-Tetri, B.A., Sanyal, A., Chalasani, N., Diehl, A.M., Terrault, N., et al. (2020) Multicenter Validation of Association between Decline in MRI-PDFF and Histologic Response in NASH. Hepatology, 72, 1219-1229.[CrossRef] [PubMed]
[21]	Stine, J.G., Munaganuru, N., Barnard, A., Wang, J.L., Kaulback, K., Argo, C.K., et al. (2021) Change in MRI-PDFF and Histologic Response in Patients with Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 19, 2274-2283.e5.[CrossRef] [PubMed]
[22]	Tamaki, N., Munaganuru, N., Jung, J., Yonan, A.Q., Loomba, R.R., Bettencourt, R., et al. (2021) Clinical Utility of 30% Relative Decline in MRI-PDFF in Predicting Fibrosis Regression in Non-Alcoholic Fatty Liver Disease. Gut, 71, 983-990.[CrossRef] [PubMed]
[23]	Chen, Y., Laevens, B.P.M., Lemainque, T., Müller-Franzes, G.A., Seibel, T., Dlugosch, C., et al. (2025) Deep Learning Reveals Liver MRI Features Associated with pnpla3 I148M in Steatotic Liver Disease. Liver International, 45, e70164.[CrossRef] [PubMed]
[24]	Zhu, G., Song, Y., Lu, Z., Yi, Q., Xu, R., Xie, Y., et al. (2025) Machine Learning Models for Predicting Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence Using Basic Demographic and Clinical Characteristics. Journal of Translational Medicine, 23, Article No. 381.[CrossRef] [PubMed]
[25]	McTeer, M., Applegate, D., Mesenbrink, P., Ratziu, V., Schattenberg, J.M., Bugianesi, E., et al. (2024) Machine Learning Approaches to Enhance Diagnosis and Staging of Patients with MASLD Using Routinely Available Clinical Information. PLOS ONE, 19, e0299487.[CrossRef] [PubMed]
[26]	Pugliesi, R.A., Ben Mansour, K., Apitzsch, J., Papachristodoulou, A., Rafailidis, V. and Katz, D.S. (2025) Meta-Analysis of AI Integration in Abdominal Imaging for Liver Fibrosis and MASLD: Evaluating Diagnostic Accuracy and Clinical Impact. Journal of Clinical Medicine, 14, Article No. 8466.[CrossRef]